Integra LifeSciences Holdings Corp. has opened its first Asia business office in Shanghai, China, as part of an ongoing expansion to serve one of the world's fastest developing medical device markets. Stuart Essig, Integra's CEO, officiated at the grand opening ceremony of the office, which is located at the People's Square area of Huangpu District. Dignitaries from the Shanghai Food and Drug Administration (SFDA), relevant governmental departments, Integra employees, and members of the local media attended the event.

“China's rapidly growing economy has created a significant medical device market that presents Integra with major growth opportunities,” says Essig. “This is an important milestone for our company and a clear indication of the importance we place in the area."

Alan Eng will manage the new office as Integra's Greater China general manager. Eng has more than 20 years of China multinational healthcare company experience. "I am extremely honored to lead Integra's first office in Asia," says Eng. "With an initial staff of five, we aim to establish a stronger distribution network to greatly enhance our services to our customers in China, Hong Kong, and Taiwan."

One of Integra's strengths is its diverse product categories. It is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Its orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, wound repair, and spine. Integra says it distinguishes itself by emphasizing the importance of the field of regenerative medicine, which it defines as surgical implants derived from its proprietary collagen matrix technology.

"Having a direct presence in China enhances our local capability, supports our commitment to this important region, and allows us to offer innovative healthcare solutions for a vast patient population," says JoAnne Harla, Integra's vice president for Latin America, Asia Pacific, and Canada. "Initially, we will focus on our neurosurgical business, but our future plans include product introductions in spine and orthobiologics, and an expansion of our existing orthopedics business."